Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

1.

No exacerbation of perihematomal edema with intraventricular tissue plasminogen activator in patients with spontaneous intraventricular hemorrhage.

Ziai W, Moullaali T, Nekoovaght-Tak S, Ullman N, Brooks JS, Morgan TC, Hanley DF.

Neurocrit Care. 2013 Jun;18(3):354-61. doi: 10.1007/s12028-013-9826-1.

PMID:
23463422
[PubMed - indexed for MEDLINE]
2.

Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intracerebral hemorrhage.

Ducruet AF, Hickman ZL, Zacharia BE, Grobelny BT, Narula R, Guo KH, Claassen J, Lee K, Badjatia N, Mayer SA, Connolly ES Jr.

Neurosurgery. 2010 Apr;66(4):648-55. doi: 10.1227/01.NEU.0000360374.59435.60.

PMID:
20305489
[PubMed - indexed for MEDLINE]
3.

Intraventricular fibrinolysis does not increase perihemorrhagic edema after intracerebral hemorrhage.

Volbers B, Wagner I, Willfarth W, Doerfler A, Schwab S, Staykov D.

Stroke. 2013 Feb;44(2):362-6. doi: 10.1161/STROKEAHA.112.673228. Epub 2013 Jan 10.

PMID:
23306318
[PubMed - indexed for MEDLINE]
Free Article
4.

Safety of intraventricular hemorrhage (IVH) thrombolysis based on CT localization of external ventricular drain (EVD) fenestrations and analysis of EVD tract hemorrhage.

Jackson DA, Patel AV, Darracott RM, Hanel RA, Freeman WD, Hanley DF.

Neurocrit Care. 2013 Aug;19(1):103-10. doi: 10.1007/s12028-012-9713-1.

PMID:
22544476
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Minimally invasive evacuation of spontaneous intracerebral hemorrhage using sonothrombolysis.

Newell DW, Shah MM, Wilcox R, Hansmann DR, Melnychuk E, Muschelli J, Hanley DF.

J Neurosurg. 2011 Sep;115(3):592-601. doi: 10.3171/2011.5.JNS10505. Epub 2011 Jun 10.

PMID:
21663412
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Morphological changes following experimental intraventricular haemorrhage and intraventricular fibrinolytic treatment with recombinant tissue plasminogen activator.

Mayfrank L, Kim Y, Kissler J, Delsing P, Gilsbach JM, Schröder JM, Weis J.

Acta Neuropathol. 2000 Nov;100(5):561-7.

PMID:
11045679
[PubMed - indexed for MEDLINE]
7.

Drainage efficiency with dual versus single catheters in severe intraventricular hemorrhage.

Hinson HE, Melnychuk E, Muschelli J, Hanley DF, Awad IA, Ziai WC.

Neurocrit Care. 2012 Jun;16(3):399-405. doi: 10.1007/s12028-011-9569-9.

PMID:
21681594
[PubMed - indexed for MEDLINE]
8.

Addition of intravenous N-methyl-D-aspartate receptor antagonists to local fibrinolytic therapy for the optimal treatment of experimental intracerebral hemorrhages.

Thiex R, Weis J, Krings T, Barreiro S, Yakisikli-Alemi F, Gilsbach JM, Rohde V.

J Neurosurg. 2007 Feb;106(2):314-20.

PMID:
17410717
[PubMed - indexed for MEDLINE]
9.

Intraclot recombinant tissue-type plasminogen activator reduces perihematomal edema and mortality in patients with spontaneous intracerebral hemorrhage.

Lian LF, Xu F, Tang ZP, Xue Z, Liang QM, Hu Q, Zhu WH, Kang HC, Liu XY, Wang FR, Zhu SQ.

J Huazhong Univ Sci Technolog Med Sci. 2014 Apr;34(2):165-71. doi: 10.1007/s11596-014-1252-x. Epub 2014 Apr 8.

PMID:
24710926
[PubMed - indexed for MEDLINE]
10.

Ventricular dilatation in experimental intraventricular hemorrhage in pigs. Characterization of cerebrospinal fluid dynamics and the effects of fibrinolytic treatment.

Mayfrank L, Kissler J, Raoofi R, Delsing P, Weis J, Küker W, Gilsbach JM.

Stroke. 1997 Jan;28(1):141-8.

PMID:
8996503
[PubMed - indexed for MEDLINE]
Free Article
11.

Factors affecting clot lysis rates in patients with spontaneous intraventricular hemorrhage.

Ziai WC, Muschelli J, Thompson CB, Keyl PM, Lane K, Shao S, Hanley DF.

Stroke. 2012 May;43(5):1234-9. doi: 10.1161/STROKEAHA.111.641050. Epub 2012 Mar 1.

PMID:
22382155
[PubMed - indexed for MEDLINE]
Free Article
12.

Evaluation of intraventricular hemorrhage assessment methods for predicting outcome following intracerebral hemorrhage.

Hwang BY, Bruce SS, Appelboom G, Piazza MA, Carpenter AM, Gigante PR, Kellner CP, Ducruet AF, Kellner MA, Deb-Sen R, Vaughan KA, Meyers PM, Connolly ES Jr.

J Neurosurg. 2012 Jan;116(1):185-92. doi: 10.3171/2011.9.JNS10850. Epub 2011 Oct 14.

PMID:
21999319
[PubMed - indexed for MEDLINE]
13.

Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: pilot study of treatment with intraventricular tissue plasminogen activator.

Varelas PN, Rickert KL, Cusick J, Hacein-Bey L, Sinson G, Torbey M, Spanaki M, Gennarelli TA.

Neurosurgery. 2005 Feb;56(2):205-13; discussion 205-13.

PMID:
15670368
[PubMed - indexed for MEDLINE]
14.

Dose effect of intraventricular fibrinolysis in ventricular hemorrhage.

Staykov D, Wagner I, Volbers B, Huttner HB, Doerfler A, Schwab S, Bardutzky J.

Stroke. 2011 Jul;42(7):2061-4. doi: 10.1161/STROKEAHA.110.608190. Epub 2011 May 5.

PMID:
21546475
[PubMed - indexed for MEDLINE]
Free Article
15.

Resolution of intraventricular hemorrhage varies by ventricular region and dose of intraventricular thrombolytic: the Clot Lysis: Evaluating Accelerated Resolution of IVH (CLEAR IVH) program.

Webb AJ, Ullman NL, Mann S, Muschelli J, Awad IA, Hanley DF.

Stroke. 2012 Jun;43(6):1666-8. doi: 10.1161/STROKEAHA.112.650523. Epub 2012 Apr 3.

PMID:
22474059
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial.

Morgan T, Awad I, Keyl P, Lane K, Hanley D.

Acta Neurochir Suppl. 2008;105:217-20.

PMID:
19066112
[PubMed - indexed for MEDLINE]
17.

Intraventricular thrombolysis with rt-PA in patients with intraventricular hemorrhage.

Dunatov S, Antoncic I, Bralic M, Jurjevic A.

Acta Neurol Scand. 2011 Nov;124(5):343-8. doi: 10.1111/j.1600-0404.2010.01481.x. Epub 2011 Feb 8.

PMID:
21303348
[PubMed - indexed for MEDLINE]
18.

Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema.

Mould WA, Carhuapoma JR, Muschelli J, Lane K, Morgan TC, McBee NA, Bistran-Hall AJ, Ullman NL, Vespa P, Martin NA, Awad I, Zuccarello M, Hanley DF; MISTIE Investigators.

Stroke. 2013 Mar;44(3):627-34. doi: 10.1161/STROKEAHA.111.000411. Epub 2013 Feb 7.

PMID:
23391763
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage.

Mayfrank L, Lippitz B, Groth M, Bertalanffy H, Gilsbach JM.

Acta Neurochir (Wien). 1993;122(1-2):32-8. Erratum in: Acta Neurochir (Wien) 1994;126(2-4):201.

PMID:
8333306
[PubMed - indexed for MEDLINE]
20.

Tissue plasminogen activator for the treatment of intraventricular hematoma: the dose-effect relationship.

Wang YC, Lin CW, Shen CC, Lai SC, Kuo JS.

J Neurol Sci. 2002 Oct 15;202(1-2):35-41.

PMID:
12220690
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk